Cargando…

An Immune-Competent Murine Model to Study Elimination of AAV-Transduced Hepatocytes by Capsid-Specific CD8(+) T Cells

Multiple independent adeno-associated virus (AAV) gene therapy clinical trials for hemophilia B, utilizing different AAV serotypes, have reported a vector dose-dependent loss of circulating factor IX (FIX) protein associated with capsid-specific CD8(+) T cell (Cap-CD8) elimination of transduced hepa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palaschak, Brett, Marsic, Damien, Herzog, Roland W., Zolotukhin, Sergei, Markusic, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415329/ https://www.ncbi.nlm.nih.gov/pubmed/28480313 http://dx.doi.org/10.1016/j.omtm.2017.04.004

Ejemplares similares

Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models
por: Markusic, David M., et al.
Publicado: (2017)

Potential for cellular stress response to hepatic factor VIII expression from AAV vector
por: Zolotukhin, Irene, et al.
Publicado: (2016)

Engineering and In Vitro Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced Seroreactivity
por: Biswas, Moanaro, et al.
Publicado: (2020)

B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With Rapamycin
por: Biswas, Moanaro, et al.
Publicado: (2020)

Identification of Novel Retinal Pericyte-Targeting rAAV Vectors Through Directed Evolution
por: Patel, Dwani D., et al.
Publicado: (2022)

Single amino acid insertion allows functional transduction of murine hepatocytes with human liver tropic AAV capsids
por: Cabanes-Creus, Marti, et al.
Publicado: (2021)

Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production
por: Halbert, Christine L., et al.
Publicado: (2010)

High-accuracy biodistribution analysis of adeno-associated virus variants by double barcode sequencing
por: Marsic, Damien, et al.
Publicado: (2015)

Rational Design of AAV-rh74, AAV3B, and AAV8 with Limited Liver Targeting
por: Chan, Christopher, et al.
Publicado: (2023)

AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
por: Hui, Daniel J, et al.
Publicado: (2015)

Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassette
por: Kumar, Sandeep R.P., et al.
Publicado: (2021)

Effect of CpG Depletion of Vector Genome on CD8(+) T Cell Responses in AAV Gene Therapy
por: Bertolini, Thais B., et al.
Publicado: (2021)

Exploring the Comprehensive Kozak Sequence Landscape for AAV Production in Sf9 System
por: Kondratov, Oleksandr, et al.
Publicado: (2023)

Chemical modification of AAV9 capsid with N-ethyl maleimide alters vector tissue tropism
por: Mulcrone, Patrick L., et al.
Publicado: (2023)

Dynamics of antigen presentation to transgene product-specific CD4(+) T cells and of Treg induction upon hepatic AAV gene transfer
por: Perrin, George Q, et al.
Publicado: (2016)

Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B
por: Rogers, Geoffrey L, et al.
Publicado: (2014)

Immune Response Mechanisms against AAV Vectors in Animal Models
por: Martino, Ashley T., et al.
Publicado: (2019)

Editorial: Immunogenicity and toxicity of AAV gene therapy
por: Bradbury, Allison, et al.
Publicado: (2023)

Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS
por: Lam, Anh K., et al.
Publicado: (2022)

Removal of Endotoxin from rAAV Samples Using a Simple Detergent-Based Protocol
por: Kondratova, Liudmyla, et al.
Publicado: (2019)

Tailoring the AAV2 capsid vector for bone-targeting
por: Alméciga-Díaz, Carlos J., et al.
Publicado: (2018)

Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
por: Büning, Hildegard, et al.
Publicado: (2019)

Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy
por: Gehrke, Miranda, et al.
Publicado: (2022)

The HLA class-II immunopeptidomes of AAV capsids proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2022)

The HLA class I immunopeptidomes of AAV capsid proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2023)

The hunt for novel AAV capsids with improved cardiac tropism
por: Miguel-dos-Santos, Rodrigo, et al.
Publicado: (2023)

Experimental Variables that Affect Human Hepatocyte AAV Transduction in Liver Chimeric Mice
por: Zou, Chenhui, et al.
Publicado: (2020)

Helper-free Production of Laboratory Grade AAV and Purification by Iodixanol Density Gradient Centrifugation
por: Crosson, Sean M., et al.
Publicado: (2018)

Tolerance Induction to Cytoplasmic β-Galactosidase by Hepatic AAV Gene Transfer — Implications for Antigen Presentation and Immunotoxicity
por: Martino, Ashley T., et al.
Publicado: (2009)

Site-Specific N-Glycosylation on the AAV8 Capsid Protein
por: Aloor, Arya, et al.
Publicado: (2018)

Cross-Packaging and Capsid Mosaic Formation in Multiplexed AAV Libraries
por: Schmit, Pauline F., et al.
Publicado: (2019)

Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders
por: Pavlou, Marina, et al.
Publicado: (2021)

AAV- based vector improvements unrelated to capsid protein modification
por: Shitik, Ekaterina M., et al.
Publicado: (2023)

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins
Publicado: (2023)

Gene Therapy-Induced Antigen-Specific Tregs Inhibit Neuro-inflammation and Reverse Disease in a Mouse Model of Multiple Sclerosis
por: Keeler, Geoffrey D., et al.
Publicado: (2018)

Adeno-associated Virus (AAV) Capsid Chimeras with Enhanced Infectivity Reveal a Core Element in the AAV Genome Critical for both Cell Transduction and Capsid Assembly
por: Viney, Lydia, et al.
Publicado: (2021)

Applying machine learning to predict viral assembly for adeno-associated virus capsid libraries
por: Marques, Andrew D., et al.
Publicado: (2020)

Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS
por: Kanaan, Nicholas M., et al.
Publicado: (2017)

Microglia-specific targeting by novel capsid-modified AAV6 vectors
por: Rosario, Awilda M, et al.
Publicado: (2016)

Ancestral library identifies conserved reprogrammable liver motif on AAV capsid
por: Zinn, Eric, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7rdghpmdtcbcem1o0ura89kngh